Burt Wealth Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Burt Wealth Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-506	Closed	-$2K	–	388
2020 Q3	$2K	Hold	506	–	–	﹤0.01%	342
2020 Q2	$2K	Hold	506	–	–	﹤0.01%	328
2020 Q1	$2K	Hold	506	–	–	﹤0.01%	338
2019 Q4	$2K	Hold	506	–	–	﹤0.01%	316
2019 Q3	$1K	Hold	506	–	–	﹤0.01%	325
2019 Q2	$4K	Hold	506	–	–	﹤0.01%	301
2019 Q1	$7K	Hold	506	–	–	﹤0.01%	289
2018 Q4	$7K	Hold	506	–	–	﹤0.01%	286
2018 Q3	$11K	Hold	506	–	–	0.01%	285
2018 Q2	$8K	Buy	+506	New	+$8.88K	﹤0.01%	292

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Burt Wealth Advisors's AMRX Position: Q4 2020 in Review

Burt Wealth Advisors sold out of Amneal Pharmaceuticals (AMRX) in Q4 2020, closing a stake of 506 shares — an estimated $2K sold.

Burt Wealth Advisors first reported a position in AMRX in Q2 2018 and held it in 10 quarters. The position peaked at $11K in Q3 2018. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

Burt Wealth Advisors reported no remaining Amneal Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Burt Wealth Advisors sold 506 Amneal Pharmaceuticals shares in Q4 2020, an estimated $2K.
Burt Wealth Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 10 quarters.
Burt Wealth Advisors's Amneal Pharmaceuticals position peaked at $11K in Q3 2018.
133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on Burt Wealth Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.